Compare Sanofi India with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs FULFORD INDIA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA FULFORD INDIA SANOFI INDIA/
FULFORD INDIA
 
P/E (TTM) x 39.5 398.8 9.9% View Chart
P/BV x 8.0 6.2 129.4% View Chart
Dividend Yield % 1.1 0.1 1,279.9%  

Financials

 SANOFI INDIA   FULFORD INDIA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
FULFORD INDIA
Mar-14
SANOFI INDIA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs6,840942 726.1%   
Low Rs4,630450 1,028.9%   
Sales per share (Unadj.) Rs1,203.1691.4 174.0%  
Earnings per share (Unadj.) Rs165.311.5 1,441.9%  
Cash flow per share (Unadj.) Rs209.915.4 1,366.3%  
Dividends per share (Unadj.) Rs84.002.00 4,200.0%  
Dividend yield (eoy) %1.50.3 509.7%  
Book value per share (Unadj.) Rs963.6380.0 253.6%  
Shares outstanding (eoy) m23.033.90 590.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.81.0 473.5%   
Avg P/E ratio x34.760.7 57.1%  
P/CF ratio (eoy) x27.345.3 60.3%  
Price / Book Value ratio x6.01.8 324.9%  
Dividend payout %50.817.4 291.3%   
Avg Mkt Cap Rs m132,0782,714 4,865.8%   
No. of employees `0003.30.4 743.5%   
Total wages/salary Rs m4,068505 805.5%   
Avg. sales/employee Rs Th8,393.86,073.0 138.2%   
Avg. wages/employee Rs Th1,232.41,137.4 108.3%   
Avg. net profit/employee Rs Th1,153.0100.7 1,145.2%   
INCOME DATA
Net Sales Rs m27,7082,696 1,027.6%  
Other income Rs m897125 715.3%   
Total revenues Rs m28,6052,822 1,013.7%   
Gross profit Rs m6,235-46 -13,437.5%  
Depreciation Rs m1,02715 6,756.6%   
Interest Rs m710 73.7%   
Profit before tax Rs m6,09854 11,230.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,29210 23,875.0%   
Profit after tax Rs m3,80645 8,514.5%  
Gross profit margin %22.5-1.7 -1,307.7%  
Effective tax rate %37.617.7 212.6%   
Net profit margin %13.71.7 828.6%  
BALANCE SHEET DATA
Current assets Rs m15,9221,738 916.0%   
Current liabilities Rs m6,235545 1,144.7%   
Net working cap to sales %35.044.3 79.0%  
Current ratio x2.63.2 80.0%  
Inventory Days Days6448 131.3%  
Debtors Days Days214 484.7%  
Net fixed assets Rs m7,53912 63,352.9%   
Share capital Rs m23039 589.7%   
"Free" reserves Rs m21,9621,443 1,522.0%   
Net worth Rs m22,1921,482 1,497.4%   
Long term debt Rs m00-   
Total assets Rs m29,8392,077 1,436.8%  
Interest coverage x872.16.7 12,986.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 71.5%   
Return on assets %12.82.6 489.6%  
Return on equity %17.23.0 568.6%  
Return on capital %27.54.3 639.0%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m7,58717 44,110.5%   
Fx outflow Rs m7,145673 1,061.4%   
Net fx Rs m442-656 -67.4%   
CASH FLOW
From Operations Rs m3,73990 4,154.4%  
From Investments Rs m-731105 -698.9%  
From Financial Activity Rs m-1,972-14 13,985.8%  
Net Cashflow Rs m1,036181 574.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 3.8 378.9%  
FIIs % 14.6 0.1 14,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 21.2 49.5%  
Shareholders   15,184 4,783 317.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ORCHID PHARMA  WYETH  TORRENT PHARMA  SUVEN LIFE SCIENCES  DR. REDDYS LAB  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 12, 2021 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - STERLING BIOTECH COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS